VANGUARD GROUP INC - 31 Dec 2025 SCHEDULE 13G/A Report for Coherus Oncology Inc Common Stock (CHRS)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Coherus Oncology Inc Common Stock
Symbol: CHRS
Shares outstanding: 120,975,790 shares
Disclosed Ownership: 10,028,893 shares
Ownership: 8.3%
Form type: SCHEDULE 13G/A
Filing time: 30 Jan 2026, 15:27:59 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	8.3%	10,028,893	0	815,663	Ashley Grim	Head of Global Fund Administration